Cover Image
市場調查報告書

全球外科介入性心臟血管治療趨勢:2015-2022年

Global Dynamics of Surgical and Interventional Cardiovascular Procedures 2015-2022

出版商 MedMarket Diligence, LLC 商品編碼 358722
出版日期 內容資訊 英文 350 Pages; 173 Exhibits
商品交期: 最快1-2個工作天內
價格
Back to Top
全球外科介入性心臟血管治療趨勢:2015-2022年 Global Dynamics of Surgical and Interventional Cardiovascular Procedures 2015-2022
出版日期: 2016年08月15日 內容資訊: 英文 350 Pages; 173 Exhibits
簡介

本報告提供全球外科介入性心臟血管治療趨勢調查,成為外科介入性治療對象的心臟血管症狀種類與概要,介入性治療及外科手術的治療數量的變化與預測,全球主要國家的醫療簡介等彙整資料。

摘要整理

第1章 成為外科治療及經導管介入性對象的一般急性、慢性心血管症狀

  • 心肌疾病
    • 缺血性心臟疾病、心臟衰竭
    • 急性心肌梗塞
    • 心源性休克
    • 心臟衰竭
      • 心臟衰竭的分類
  • 週邊動脈疾病
    • 週邊動脈疾病、嚴重下肢缺血
    • 主動脈瘤
  • 末梢靜脈疾病
    • 深部靜脈血栓症、肺動脈栓塞
    • 慢性靜脈功能不全
  • 腦血管障礙
    • 急性中風
      • 缺血性中風
      • 出血性中風
  • 器質性心臟疾病
    • 先天性心臟缺損症
    • 心瓣膜障礙
  • 心律紊亂
    • 心搏過緩
    • 上室性心搏過速
      • 心房纖維顫動
    • 心室心搏過速

第2章 外科的治療及介入性治療的治療數量現況、預測

  • 缺血性心臟疾病治療
    • 冠狀動脈側道術
    • 經皮冠狀動脈介入治療
  • 急性、慢性心臟衰竭管理上機械性循環補助
    • 包含MCS (VAD) 植治療數量
  • 末梢動脈重組血液循環重組
    • 下肢動脈血液循環重組的側道移植術
    • 末梢經導管術
  • 主動脈瘤修復
    • 主動脈瘤的外科修復
    • 血管內血管支架的腹部主動脈血管瘤修復
    • TAA的血管內修復
    • 主動脈瘤修復的治療數量
  • 肺動脈栓塞的預防和慢性靜脈功能不全、深部靜脈血栓症的治療
    • 下腔靜脈 (IVC) 過濾器拘留
    • CVI的靜脈內切除
    • 機器式、混合法血栓消除法
    • 血管支架置入
  • 急性中風的預防、治療
    • 高度頸動脈狹窄管理
    • 左心耳封閉
    • 腦血栓消除術
    • 出血性中風預防的腦動脈瘤、AVM的修復
  • 容器質性心臟疾病的管理
    • 先天性心臟缺損的修復
    • 心臟瓣膜修復、置換
  • 心律管理
    • 植入式脈衝發生系統
    • 心律不整切除治療

第3章 各國醫療簡介

  • 美國
  • 西歐主要國家
    • 歐洲的醫療部門概要
    • 國家概況
      • 法國
      • 德國
      • 義大利
      • 西班牙
      • 英國
  • 亞洲主要國家
    • 中國
    • 印度
    • 日本
目錄
Product Code: C500

This report covers surgical and interventional therapeutic procedures commonly used in the management of acute and chronic conditions affecting myocardium and vascular system. The latter include ischemic heart disease (and its life threatening manifestations like AMI, cardiogenic shock, etc.); heart failure; structural heart disorders (valvular abnormalities and congenital heart defects); peripheral artery disease (and limb and life threatening critical limb ischemia); aortic disorders (AAA, TAA and aortic dissections); acute and chronic venous conditions (such as deep venous thrombosis, pulmonary embolism and chronic venous insufficiency); neurovascular pathologies associated with high risk of hemorrhagic and ischemic stroke (such as cerebral aneurysms and AVMs, and high-grade carotid/intracranial stenosis); and cardiac rhythm disorders (requiring correction with implantable pulse generators/IPG or arrhythmia ablation).

The report offers current assessment and projected procedural dynamics (2015 to 2022) for primary market geographies (e.g., United States, Largest Western European Countries, and Major Asian States) as well as the rest-of-the-world.

The cited procedural assessments and forecasts are based on the systematic analysis of a multiplicity of sources including (but not limited to):

  • Latest and historic company SEC filings, corporate presentations, and interviews with product management and marketing staffers;
  • Data released by authoritative international institutions (such as OECD and WHO), and national healthcare authorities;
  • Statistical updates and clinical practice guidelines from professional medical associations (like AHA, ACC, European Society of Cardiology, etc.);
  • Specialty presentations at major professional conferences (e.g., TCT, AHA Scientific Sessions, EuroPCR, etc.);
  • Publications in major medical journals (JAMA, NEJM) and specialty magazines (CathLab digest, Endovascular Today, etc.);
  • Findings from relevant clinical trials;
  • Feedback from leading clinicians (end-users) in the field on device/procedure utilization trends and preferences; and
  • Policy papers by major medical insurance carriers on uses of particular surgical and interventional tools and techniques, their medical necessity and reimbursement.

Surgical and Interventional Procedures Covered:

  • Coronary artery bypass graft (CABG) surgery
  • Coronary angioplasty and stenting
  • Lower extremity arterial bypass surgery
  • Percutaneous transluminal angioplasty (PTA) with and without bare metal and drug-eluting stenting
  • Peripheral drug-coated balloon angioplasty
  • Peripheral atherectomy
  • Surgical and endovascular aortic aneurysm repair
  • Vena cava filter placement
  • Endovenous ablation
  • Mechanical venous thrombectomy
  • Venous angioplasty and stenting
  • Carotid endarterectomy
  • Carotid artery stenting
  • Cerebral thrombectomy
  • Cerebral aneurysm and AVM surgical clipping
  • Cerebral aneurysm and AVM coiling & flow diversion
  • Left Atrial Appendage closure
  • Heart valve repair and replacement surgery
  • Transcatheter valve repair and replacement
  • Congenital heart defect repair
  • Percutaneous and surgical placement of temporary and permanent mechanical cardiac support devices
  • Pacemaker implantation
  • Implantable cardioverter defibrillator placement
  • Cardiac resynchronization therapy device placement
  • Standard SVT & VT ablation
  • Transcatheter AFib ablation

Table of Contents

Executive Summary

SECTION 1: Common Acute and Chronic Cardiovascular Conditions Targeted by Surgical and Transcatheter Intervenions

  • 1.1 Circulatory Myocardial Disorders
    • 1.1.1 Ischemic Heart Disease and Heart Failure
    • 1.1.2 Acute Myocardial Infarction
    • 1.1.3 Cardiogenic Shock
    • 1.1.4 Heart Failure
      • 1.1.4.1 Classifications of Heart Failure
  • 1.2 Peripheral Artery Disorders
    • 1.2.1 Peripheral Artery Disease and Critical Limb Ischemia
    • 1.2.2 Aortic Aneurysm
  • 1.3 Peripheral Venous Disorders
    • 1.3.1 Deep Venous Thrombosis and Pulmonary Embolism
    • 1.3.2 Chronic Venous Insufficiency
  • 1.4 Cerebrovascular Disorders
    • 1.4.1 Acute Stroke
      • 1.4.1.1 Ischemic Stroke
      • 1.4.1.2 Hemorrhagic Stroke
  • 1.5 Structural Heart Disorders
    • 1.5.1 Congenital Heart Defects
    • 1.5.2 Heart Valve Disorders
  • 1.6 Cardiac Rhythm Disorders
    • 1.6.1 Bradycardia
    • 1.6.2 Supraventricular Tachycardia
      • 1.6.2.1 Atrial Fibrillation
    • 1.6.3 Ventricular Tachycardia

SECTION 2: Current and Projected Volumes of Therapeutic Interventional and Surgical Cardiovascular Procedures

  • 2.1 Ischemic Heart Disease Treatment [purchase this section and subsections: $475 - order]
    • 2.1.1 Coronary Artery Bypass Graft Surgery
      • 2.1.1.1 Less Invasive Variations of CABG
      • 2.1.1.2 Patient Indications and Outcomes
      • 2.1.1.3 CABG Utilization Trends and Procedure Volumes
    • 2.1.2 Percutaneous Coronary Interventions
      • 2.1.2.1 Percutaneous Transluminal Coronary Angioplasty & Stenting
        • 2.1.2.1.1 PTCA/Stenting Procedure Volumes
  • 2.2 Mechanical Circulatory Support in Acute and Chronic Heart Failure Management [purchase this section and subsections: $795 - order]
    • 2.2.1 MCS (VAD) Placement Procedure Volumes
  • 2.3 Peripheral Artery Revascularization [purchase this section and subsections: $795 - order]
    • 2.3.1 Bypass Graft Surgery for Revascularization of the Lower Extremity Arterial Occlusions
      • 2.3.1.1 Femoro-Popliteal Bypass Surgery
      • 2.3.1.2 Aortoiliofemoral Bypass Graft Surgery
      • 2.3.1.3 Distal Tibial-Peroneal Vacsular Reconstruction
      • 2.3.1.4 Lower Extremity Surgical Bypass Grafting Procedure Volumes
    • 2.3.1 Peripheral Transcatheter Interventions
      • 2.3.1.1 Percutaneous Transluminal Angioplasty (PTA)
      • 2.3.1.2 Lower Extremity Stenting
      • 2.3.1.3 Lower Extremity Arterial Angioplasty and Stenting Procedure Volumes
      • 2.3.1.4 Drug-Coated Balloon Angioplasty
      • 2.3.1.5 DCB Angioplasty Procedure Volumes
      • 2.3.1.6 Mechanical Atherectomy
      • 2.3.1.7 Atherectomy Procedure Volumes
      • 2.3.1.8 Catheter-Directed Thrombolysis and Thrombectomy
  • 2.4 Aortic Aneurysm Repair [purchase this section and subsections: $395 - order]
    • 2.4.1 Surgical Repair of Aortic Aneurysms
    • 2.4.2 Abdominal Aortic Aneurysm Repair with Endovascular Stent-Grafts
      • 2.4.2.1 Limitations of Endovascular AAA Repair
    • 2.4.3 Endovascular Repair of TAA
    • 2.4.4 Aortic Aneurysm Repair Procedure Volumes
  • 2.5 Prophylaxis of Pulmonary Embolism and Treatment of Chronic Venous Insufficiency and Deep Venous Thrombosis [purchase this section and subsections: $645 - order]
    • 2.5.1 Inferior Vena Cava (IVC) Filter Placement
      • 2.5.1.1 IVC Filter Placement Procedure Volumes
    • 2.5.2 Endovenous Ablation for CVI
      • 2.5.2.1 2Endovenous Ablation Procedure Volumes
    • 2.5.3 Mechanical and Hybrid Thrombectomy for DVT
      • 2.5.3.1 Accumulated Clinical Experience
      • 2.5.3.2 Venous Thrombectomy Procedure Volumes
    • 2.5.4 Venous Stenting
      • 2.5.4.1 Accumulated Clinical Experience
      • 2.5.1.2 Venous Stenting Procedure Volumes
  • 2.6 Acute Stroke Prophylaxis and Treatment [purchase this section and subsections: $675 - order]
    • 2.6.1 High-Grade Carotid Artery Stenosis Management
      • 2.6.1.1 Carotid Endarterectomy
      • 2.6.1.2 Carotid Artery Stenting
        • 2.6.1.2.1 CREST Trial Results
      • 2.6.1.3 Carotid Endarterectomy and Stenting Procedure Volumes
    • 2.6.2 Left Atrial Appendage Closure
      • 2.6.2.1 Surgical Closure of Left Atrial Appendage
      • 2.6.2.2 Endovascular Closure of Left Atrial Appendage
        • 2.6.2.2.1 Clinical Experience with Endovascular LAA Closure Systems
        • 2.6.2.2.2 Left Atrial Appendage Endovascular Closure Procedure Volumes
    • 2.6.3 Cerebral Thrombectomy
      • 2.6.3.1 Clinical Experience with Cerebral Thrombectomy Systems
      • 2.6.3.2 Cerebral Thrombectomy Procedure Volumes
    • 2.6.4 Cerebral Aneurysm and AVM Repair in Prophylaxis of Hemorrhagic Stroke
      • 2.6.4.1 Treatment Options
        • 2.6.4.1.1 Surgical Repair of Cerebral Aneurysms and AVMs
        • 2.6.4.1.2 Endovascular Embolization of Cerebral Aneurysms and AVMs
      • 2.6.4.2 Cerebral Aneurysm & AVM Embolization Procedure Volumes
  • 2.7 Management of Structural Heart Disorders [purchase this section and subsections: $545 - order]
    • 2.7.1 Congenital Heart Defects Repair
      • 2.7.1.1 Projected Procedure Volumes
    • 2.7.2 Heart Valve Repair and Replacement
      • 2.7.2.1 Heart Valve Surgery
      • 2.7.2.2 Percutaneous Heart Valve Repair and Replacement
      • 2.7.2.3 Projected Procedure Volumes
  • 2.8 Cardiac Rhythm Management [purchase this section and subsections: $545 - order]
    • 2.8.1 Implantable Pulse Generator Systems
      • 2.8.1.1 Cardiac Pacing Systems
      • 2.8.1.2 Implantable Cardioverter Defibrillators
      • 2.8.1.3 Cardiac Resynchronization Therapy Systems
      • 2.8.1.4 Pacemaker, ICD and CRT Device Placement Procedure Volumes
    • 2.8.2 Arrhythmia Ablation Therapy
      • 2.8.2.1 Ablation of Atrial Fibrillation
        • 2.8.2.1.1 Surgical AFib Ablation Techniques
        • 2.8.2.1.2 Catheter AFib Ablation Techniques
      • 2.8.2.2 Cardiac Arrhythmia Ablation Procedure Volumes

SECTION 3: Country Healthcare Profiles

  • 3.1 United States
  • 3.2 Major Western European States
    • 3.2.1 Overview of European Healthcare
      • 3.2.1.1 Healthcare Spending and Reforms
      • 3.2.1.2 Healthcare Facilities and Manpower
      • 3.2.1.3 Reimbursement
      • 3.2.1.4 Impact of the European Union
    • 3.2.2 National Healthcare Profiles
      • 3.2.2.1 France
      • 3.2.2.2 Germany
      • 3.2.2.3 Italy
      • 3.2.2.4 Spain
      • 3.2.2.5 United Kingdom
  • 3.3 Major Asian States
    • 3.3.1 China
    • 3.3.2 India
    • 3.3.3 Japan

List of Exhibits

  • Exhibit ES-1: Projected Global Dynamics of Interventional and Surgical Cardiovascular Procedures, 2015-2022 (#000)
  • Exhibit ES-2: Projected Geographic Dynamics and Distribution of Interventional and Surgical Cardiovascular Procedures, 2015-2022 (#000)
  • Exhibit ES-3: Projected Dynamics of Interventional and Surgical Cardiovascular Procedures, United States 2015-2022 (#000)
  • Exhibit ES-4: Projected Dynamics of Interventional and Surgical Cardiovascular Procedures, Largest Western European States, 2015-2022 (#000)
  • Exhibit ES-5: Projected Dynamics of Interventional and Surgical Cardiovascular Procedures, Major Asia-Pacific States, 2015-2022 (#000)
  • Exhibit ES-6: Projected Dynamics of Interventional and Surgical Cardiovascular Procedures, Rest-of-the-World, 2015-2022 (#000)
  • Exhibit 1-1: Ischemic Heart Disease, Facts and Figures
  • Exhibit 1-2: Acute Myocardial Infarction Facts and Figures
  • Exhibit 1-3: Cardiogenic Shock Facts and Figures
  • Exhibit 1-4: Heart Failure Facts and Figures
  • Exhibit 1-5: Peripheral Artery Disease: Facts And Figures (2015)
  • Exhibit 1-6: Aortic Aneurysm: Facts And Figures (2015)
  • Exhibit 1-7 Deep Venous Thrombosis: Facts & Figures (2015)
  • Exhibit 1-8: Chronic Venous Insufficiency: Facts And Figures (2010)
  • Exhibit 1-9: Clinical Features and Characteristics of Ischemic Stroke (2015)
  • Exhibit 1-10: Clinical Features and Characteristics of Hemorrhagic Stroke (2015)
  • Exhibit 1-11: Clinical Characteristics of the Most Prevalent Congenital Heart Defects
  • Exhibit 1-12: Congenital Heart Defects, Facts and Figures (2015)
  • Exhibit 1-13: Heart Valve Disorders Facts and Figures (2015)
  • Exhibit 1-14: Estimated and Projected Incidence and Prevalence of Common Cardiac Rhythm Disorders (2015)
  • Exhibit 2-1: Projected Global Dynamics of Interventional and Surgical Cardiovascular Procedures, 2015-2022 (#000)
  • Exhibit 2-2: Projected Geographic Dynamics and Distribution of Interventional and Surgical Cardiovascular Procedures, 2015-2022 (#000)
  • Exhibit 2-3: Projected Dynamics of Interventional and Surgical Cardiovascular Procedures, United States 2015-2022 (#000)
  • Exhibit 2-4: Projected Dynamics of Interventional and Surgical Cardiovascular Procedures, Largest Western European States, 2015-2022 (#000)
  • Exhibit 2-5: Projected Dynamics of Interventional and Surgical Cardiovascular Procedures, Major Asia-Pacific States, 2015-2022 (#000)
  • Exhibit 2-6: Projected Dynamics of Interventional and Surgical Cardiovascular Procedures, Rest-of-the-World, 2015-2022 (#000)
  • Exhibit 2-7: CABG-PCI: Projected Dynamics of Coronary Revascularization Procedures, United States, 2015-2022 (#000)
  • Exhibit 2-8: CABG-PCI: Projected Dynamics of Coronary Revascularization Procedures, Major Western Europe, 2015-2022 (#000)
  • Exhibit 2-9: CABG-PCI: Projected Dynamics of Coronary Revascularization Procedures, Major Asia-Pacific, 2015-2022 (#000)
  • Exhibit 2-10: CABG-PCI: Projected Dynamics of Coronary Revascularization Procedures, Rest-of-the-World, 2015-2022 (#000)
  • Exhibit 2-11: CABG-PCI: Projected Dynamics of Coronary Revascularization Procedures, World Total, 2015-2022 (#000)
  • Exhibit 2-12: U.S., PCI and CABG, 2016 & 2022
  • Exhibit 2-13: Western Europe, PCI and CABG, 2016 & 2022
  • Exhibit 2-14: Asia-Pacific, PCI and CABG, 2016 & 2022
  • Exhibit 2-15: Rest of World, PCI and CABG, 2016 & 2022
  • Exhibit 2-16: MCS: Projected Dynamics of Mechanical Cardiac Support (MCS) Procedures, United States, 2015-2022
  • Exhibit 2-17: MCS: Projected Dynamics of Mechanical Cardiac Support (VAD) Placement Procedures, Western Europe, 2015-2022
  • Exhibit 2-18: MCS: Projected Dynamics of Mechanical Cardiac Support (VAD) Placement Procedures, Asia-Pacific, 2015-2022
  • Exhibit 2-19: MCS: Projected Dynamics of Mechanical Cardiac Support (VAD) Placement Procedures, Rest-of-the-World, 2015-2022
  • Exhibit 2-20: MCS: Projected Dynamics of Mechanical Cardiac Support (VAD) Placement Procedures, World Total, 2015-2022
  • Exhibit 2-21: U.S., Temporary and Permanent Mechanical Support Procedures, 2016 & 2022
  • Exhibit 2-22: Western Europe, Temporary and Permanent Mechanical Support Procedures, 2016 & 2022
  • Exhibit 2-23: Asia-Pacific, Temporary and Permanent Mechanical Support Procedures, 2016 & 2022
  • Exhibit 2-24: Rest of World, Temporary and Permanent Mechanical Support Procedures, 2016 & 2022
  • Exhibit 2-25: PVD-Bypass: Projected Dynamics of Peripheral Artery Bypass Procedures, United States, 2015-2022 (#000)
  • Exhibit 2-26: PVD-Bypass: Projected Dynamics of Peripheral Artery Bypass Procedures, Major Western Europe, 2015-2022 (#000)
  • Exhibit 2-27: PVD-Bypass: Projected Dynamics of Peripheral Artery Bypass Procedures, Major Asia-Pacific, 2015-2022 (#000)
  • Exhibit 2-28: PVD-Bypass: Projected Dynamics of Peripheral Artery Bypass Procedures, Rest-of-the-World, 2015-2022 (#000)
  • Exhibit 2-29: PVD-Bypass: Projected Dynamics of Peripheral Artery Bypass Procedures, World Total, 2015-2022 (#000)
  • Exhibit 2-30: Lower Extremity Bypass, By Region, 2015-2022
  • Exhibit 2-31: LE PTA: Projected Dynamics of the Lower Extremity Angioplasty-Stenting Procedures, United States, 2015-2022 (#000)
  • Exhibit 2-32: LE PTA: Projected Dynamics of the Lower Extremity Angioplasty-Stenting Procedures, Major Western Europe, 2015-2022 (#000)
  • Exhibit 2-33: LE-PTA: Projected Dynamics of Peripheral Angioplasty-Stenting Procedures, Major Asia-Pacific, 2015-2022 (#000)
  • Exhibit 2-34: LE-PTA: Projected Dynamics of Peripheral Angioplasty-Stenting Procedures, Rest-of-the-World, 2015-2022 (#000)
  • Exhibit 2-35: LE-PTA: Projected Dynamics of Peripheral Angioplasty-Stenting Procedures, World Total, 2015-2022 (#000)
  • Exhibit 2-36: Lower Extremity Angioplasty and Drug-Eluting and Bare Metal Stent Procedures, By Region 2016
  • Exhibit 2-37: Lower Extremity Angioplasty and Drug-Eluting and Bare Metal Stent Procedures, By Region 2022
  • Exhibit 2-38: LE-DCB: Projected Dynamics of Peripheral Drug-Coated Balloon Angioplasty Procedures, United States, 2015-2022 (#000)
  • Exhibit 2-39: LE DCB: Projected Dynamics of Peripheral Drug-Coated Balloon Angioplasty Procedures, Major Western Europe, 2015-2022 (#000)
  • Exhibit 2-40: LE-DCB: Projected Dynamics of Peripheral Drug-Coated Balloon Angioplasty Procedures, Major Asia-Pacific, 2015-2022 (#000)
  • Exhibit 2-41: LE-DCB: Projected Dynamics of Peripheral Drug-Coated Balloon Angioplasty Procedures, Rest-of-the-World, 2015-2022 (#000)
  • Exhibit 2-42: LE-DCB: Projected Dynamics of Peripheral Drug-Coated Balloon Angioplasty Procedures, World Total, 2015-2022 (#000)
  • Exhibit 2-43: Lower Extremity Angioplasty, With and Without Drug-Coated Balloon, By Region 2016
  • Exhibit 2-44: Lower Extremity Angioplasty, With and Without Drug-Coated Balloon, By Region 2022
  • Exhibit 2-45: PVD-Atherectomy: Projected Dynamics of the Lower Extremity Atherectomy Procedures, United States, 2015-2022 (#000)
  • Exhibit 2-46: PVD-Atherectomy: Projected Dynamics of the Lower Extremity Atherectomy Procedures, Major Western Europe, 2015-2022 (#000)
  • Exhibit 2-47: PVD-Atherectomy: Projected Dynamics of the Lower Extremity Atherectomy Procedures, Major Asia-Pacific, 2015-2022 (#000)
  • Exhibit 2-48: PVD-Atherectomy: Projected Dynamics of the Lower Extremity Atherectomy Procedures, Rest-of-the-World, 2015-2022 (#000)
  • Exhibit 2-49: PVD-Atherectomy: Projected Dynamics of the Lower Extremity Atherectomy Procedures, World Total, 2015-2022 (#000)
  • Exhibit 2-50: Lower Extremity Atherectomy, By Region, 2016 & 2022
  • Exhibit 2-51: Thrombectomy-DVT: Projected Dynamics of DVT Targeting Thrombectomy Procedures, United States, 2015-2022 (#000)
  • Exhibit 2-52: Thrombectomy-DVT: Projected Dynamics of DVT Targeting Thrombectomy Procedures, Major Western Europe, 2015-2022 (#000)
  • Exhibit 2-53: Thrombectomy-DVT: Projected Dynamics of DVT Targeting Thrombectomy Procedures, Major Asian-Pacific States, 2015-2022 (#000)
  • Exhibit 2-54: Thrombectomy-DVT: Projected Dynamics of DVT Targeting Thrombectomy Procedures, Rest-of-the-World, 2015-2022 (#000)
  • Exhibit 2-55: Thrombectomy-DVT: Projected Dynamics of DVT Targeting Thrombectomy Procedures, World Total, 2015-2022 (#000)
  • Exhibit 2-56: DVT Thrombectomy, By Region, 2016 & 2022
  • Exhibit 2-57: AAA-TAA: Projected Dynamics of Aortic Aneurysm Repair Procedures, United States, 2015-2022 (#000)
  • Exhibit 2-58: AAA-TAA: Projected Dynamics of Aortic Aneurysm Repair Procedures, Largest Western European States, 2015-2022 (#000)
  • Exhibit 2-59: AAA-TAA: Projected Dynamics of Aortic Aneurysm Repair Procedures, Major Asian-Pacific States, 2015-2022 (#000)
  • Exhibit 2-60: AAA-TAA: Projected Dynamics of Aortic Aneurysm Repair Procedures, Rest-of-the-World, 2015-2022 (#000)
  • Exhibit 2-61: AAA-TAA: Projected Dynamics of Aortic Aneurysm Repair Procedures, World Total, 2015-2022 (#000)
  • Exhibit 2-62: U.S. Surgical and Endovascular AAA/TAA Repair, 2016 & 2022
  • Exhibit 2-63: Western Europe, Surgical and Endovascular AAA/TAA, 2016 & 2022
  • Exhibit 2-64: Asia-Pacific, Surgical and Endovascular AAA/TAA, 2016 & 2022
  • Exhibit 2-65: Rest of World, Surgical and Endovascular AAA/TAA, 2016 & 2022
  • Exhibit 2-66: VCF-PE: Projected Dynamics of Inferior Vena Cava Filter Placement Procedures, United States, 2015-2022 (#000)
  • Exhibit 2-67: VCF-PE: Projected Dynamics of Inferior Vena Cava Filter Placement Procedures, Major Western Europe, 2015-2022 (#000)
  • Exhibit 2-68: VCF-PE: Projected Dynamics of Inferior Vena Cava Filter Placement Procedures, Major Asian-Pacific States, 2015-2022 (#000)
  • Exhibit 2-69: VCF-PE: Projected Dynamics of Inferior Vena Cava Filter Placement Procedures, Rest-of-the-World, 2015-2022 (#000)
  • Exhibit 2-70: VCF-PE: Projected Dynamics of Inferior Vena Cava Filter Placement Procedures, World Total, 2015-2022 (#000)
  • Exhibit 2-71: Inferior Vena Cava Filter Placements, By Region, 2016 & 2022
  • Exhibit 2-72: CVI-EVT: Projected Dynamics of CVI-Targeting Endovenous Ablation Procedures, United States, 2015-2022 (#000)
  • Exhibit 2-73: CVI-EVT: Projected Dynamics of CVI-Targeting Endovenous Ablation Procedures, Major Western Europe, 2015-2022 (#000)
  • Exhibit 2-74: CVI-EVT: Projected Dynamics of CVI-Targeting Endovenous Ablation Procedures, Major Asian-Pacific States, 2015-2022 (#000)
  • Exhibit 2-75: CVI-EVT: Projected Dynamics of CVI-Targeting Endovenous Ablation Procedures, Rest-of-the-World, 2015-2022 (#000)
  • Exhibit 2-76: CVI-EVT: Projected Dynamics of CVI-Targeting Endovenous Ablation Procedures, World Total, 2015-2022 (#000)
  • Exhibit 2-77: Chronic Venous Insufficiency Endovenous Ablation, By Region, 2016 & 2022
  • Exhibit 2-78: Projected Dynamics of DVT Targeting Thrombectomy Procedures, United States, 2015-2022 (#000)
  • Exhibit 2-79: Thrombectomy-DVT: Projected Dynamics of DVT Targeting Thrombectomy Procedures, Major Western Europe, 2015-2022 (#000)
  • Exhibit 2-80: Thrombectomy-DVT: Projected Dynamics of DVT Targeting Thrombectomy Procedures, Major Asian-Pacific States, 2015-2022 (#000)
  • Exhibit 2-81: Thrombectomy-DVT: Projected Dynamics of DVT Targeting Thrombectomy Procedures, Rest-of-the-World, 2015-2022 (#000)
  • Exhibit 2-82: Thrombectomy-DVT: Projected Dynamics of DVT Targeting Thrombectomy Procedures, World Total, 2015-2022 (#000)
  • Exhibit 2-83: Deep Vein Thrombosis Thrombectomy, By Region, 2016 & 2022
  • Exhibit 2-84: Venous Stenting: Projected Dynamics of Venous Stenting Procedures, United States, 2015-2022 (#000)
  • Exhibit 2-85: Venous Stenting: Projected Dynamics of Venous Stenting Procedures, Major Western Europe, 2015-2022 (#000)
  • Exhibit 2-86: Venous Stenting: Projected Dynamics of Venous Stenting Procedures, Major Asian-Pacific States, 2015-2022 (#000)
  • Exhibit 2-87: Venous Stenting: Projected Dynamics of Venous Stenting Procedures, Rest-of-the-World, 2015-2022 (#000)
  • Exhibit 2-88: Venous Stenting: Projected Dynamics of Venous Stenting Procedures, World Total, 2015-2022 (#000)
  • Exhibit 2-89: Venous Stenting Procedures, By Region, 2016 & 2022
  • Exhibit 2-90: Projected Dynamics of Venous Stenting Procedures, United States, 2015-2022 (#000)
  • Exhibit 2-91: CAS-CEA: Projected Dynamics of Carotid Artery Revascularization Procedures, United States, 2015-2022 (#000)
  • Exhibit 2-92: CAS-CEA: Projected Dynamics of Carotid Artery Revascularization Procedures, Major Western Europe, 2015-2022 (#000)
  • Exhibit 2-93: CAS-CEA: Projected Dynamics of Carotid Artery Revascularization Procedures, Major Asian-Pacific States, 2015-2022 (#000)
  • Exhibit 2-94: CAS-CEA: Projected Dynamics of Carotid Artery Revascularization Procedures, Rest-of-the-World, 2015-2022 (#000)
  • Exhibit 2-95: CAS-CEA: Projected Dynamics of Carotid Artery Revascularization Procedures, World Total, 2015-2022 (#000)
  • Exhibit 2-96: U.S. Carotid Artery Procedures, 2016 & 2022
  • Exhibit 2-97: Western Europe Carotid Artery Procedures, 2016 & 2022
  • Exhibit 2-98: Asia-Pacific Carotid Artery Procedures, 2016 & 2022
  • Exhibit 2-99: Rest of World Carotid Artery Procedures, 2016 & 2022
  • Exhibit 2-100: Projected Dynamics of Left Atrial Appendix Closure Procedures, United States, 2015-2022 (#000)
  • Exhibit 2-101: Worldwide Left Atrial Appendage Closure, By Region, 2016 & 2022
  • Exhibit 2-102: Cerebral Thrombectomy: Projected Dynamics of Cerebral Thrombectomy Procedures, United States, 2015-2022 (#000)
  • Exhibit 2-103: Cerebral Thrombectomy: Projected Dynamics of Cerebral Thrombectomy Procedures, Major Western Europe, 2015-2022 (#000)
  • Exhibit 2-104: Cerebral Thrombectomy: Projected Dynamics of Cerebral Thrombectomy Procedures, Major Asian-Pacific States, 2015-2022 (#000)
  • Exhibit 2-105: Cerebral Thrombectomy: Projected Dynamics of Cerebral Thrombectomy Procedures, Rest-of-the-World, 2015-2022 (#000)
  • Exhibit 2-106: Cerebral Thrombectomy: Projected Dynamics of Cerebral Thrombectomy Procedures, World Total, 2015-2022 (#000)
  • Exhibit 2-107: Cerebral Thrombectomy, By Region, 2016 & 2022
  • Exhibit 2-108: Projected Dynamics of Cerebral Aneurysm & AVM Repair Procedures, United States, 2015-2022 (#000)
  • Exhibit 2-109: Projected Dynamics of Cerebral Aneurysm & AVM Repair Procedures, Largest Western States, 2015-2022 (#000)
  • Exhibit 2-110: Projected Dynamics of Cerebral Aneurysm & AVM Repair Procedures, Major Asia Pacific States, 2015-2022 (#000)
  • Exhibit 2-111: Projected Dynamics of Cerebral Aneurysm & AVM Repair Procedures, Rest of World, 2015-2022 (#000)
  • Exhibit 2-112: Projected Dynamics of Cerebral Aneurysm & AVM Repair Procedures, World Total, 2015-2022 (#000)
  • Exhibit 2-113: U.S. Cerebral Aneurysm and AVM Repairs, 2016 & 2022
  • Exhibit 2-114: Western Europe, Cerebral Aneurysm and AVM Repairs, 2016 & 2022
  • Exhibit 2-115: Asia-Pacific, Cerebral Aneurysm and AVM Repairs, 2016 & 2022
  • Exhibit 2-116: Rest of World, Cerebral Aneurysm and AVM Repairs, 2016 & 2022
  • Exhibit 2-117: Heart Defects: Projected Dynamics of Congenital Heart Defect Repair Procedures, United States, 2015-2022 (#000)
  • Exhibit 2-118: Heart Defects: Projected Dynamics of Congenital Heart Defect Repair Procedures, Major Western Europe, 2015-2022 (#000)
  • Exhibit 2-119: Heart Defects: Projected Dynamics of Congenital Heart Defect Repair Procedures, Major Asia-Pacific, 2015-2022 (#000)
  • Exhibit 2-120: Heart Defects: Projected Dynamics of Congenital Heart Defect Repair Procedures, Rest-of-the-World, 2015-2022 (#000)
  • Exhibit 2-121: Heart Defects: Projected Dynamics of Congenital Heart Defect Repair Procedures, World Total, 2015-2022 (#000)
  • Exhibit 2-122: Congenital Heart Defect Repairs, By Region, 2016
  • Exhibit 2-123: Congenital Heart Defect Repairs, By Region, 2022
  • Exhibit 2-124: Valves: Projected Dynamics of Heart Valve Replacement and Repair Procedures, United States, 2015-2022
  • Exhibit 2-125: Projected Dynamics of Heart Valve Replacement and Repair Procedures, Major Western Europe, 2015-2022
  • Exhibit 2-126: Valves: Projected Dynamics of Heart Valve Replacement and Repair Procedures, Major Asia-Pacific, 2015-2022
  • Exhibit 2-127: Valves: Projected Dynamics of Heart Valve Replacement and Repair Procedures, Rest-of-the-World, 2015-2022
  • Exhibit 2-128: Projected Dynamics of Heart Valve Replacement and Repair Procedures, World Total, 2015-2022
  • Exhibit 2-129: U.S. Surgical and Transcatheter Heart Valve Replacements, 2016 & 2022
  • Exhibit 2-130: Western Europe Surgical and Transcatheter Heart Valve Replacements, 2016 & 2022
  • Exhibit 2-131: Asia-Pacific Surgical and Transcatheter Heart Valve Replacements, 2016 & 2022
  • Exhibit 2-132: Rest of World Surgical and Transcatheter Heart Valve Replacements, 2016 & 2022
  • Exhibit 2-133: CRM-IPG: Projected Dynamics of Implantable Pulse Generator Placement Procedures, United States, 2015-2022 (#000)
  • Exhibit 2-134: CRM-IPG: Projected Dynamics of Implantable Pulse Generator Placement Procedures, Major Western Europe, 2015-2022 (#000)
  • Exhibit 2-135: CRM-IPG: Projected Dynamics of Implantable Pulse Generator Placement Procedures, Major Asia-Pacific, 2015-2022 (#000)
  • Exhibit 2-136: CRM-IPG: Projected Dynamics of Implantable Pulse Generator Placement Procedures, Rest-of-the-World, 2015-2022 (#000)
  • Exhibit 2-137: CRM-IPG: Projected Dynamics of Implantable Pulse Generator Placement Procedures, World Total, 2015-2022 (#000)
  • Exhibit 2-138: Implantable Pulse Generator Placements, By Region, 2016 & 2022
  • Exhibit 2-139: AFib Ablation: Projected Dynamics of EP - AFib Ablation Procedures, United States, 2015-2022 (#000)
  • Exhibit 2-140: EP-AFib Ablation: Projected Dynamics of EP - AFib Ablation Procedures, Major Western Europe, 2015-2022 (#000)
  • Exhibit 2-141: AFib Ablation: Projected Dynamics of EP - AFib Ablation Procedures, Major Asia-Pacific, 2015-2022 (#000)
  • Exhibit 2-142: EP-AFib Ablation: Projected Dynamics of EP - AFib Ablation Procedures, Rest-of-the-World, 2015-2022 (#000)
  • Exhibit 2-143: EP-AFib Ablation: Projected Dynamics of EP - AFib Ablation Procedures, World Total, 2015-2022 (#000)
  • Exhibit 2-144: Atrial Fibrillation Procedures, By Region, 2016 & 2022
  • Exhibit 3-1: United States, Selected Healthcare/Public Health Indicators, 2015
  • Exhibit 3-2: France, Selected Healthcare/Public Health Indicators, 2015
  • Exhibit 3-4: Italy, Selected Healthcare/Public Health Indicators, 2015
  • Exhibit 3-5: Spain, Selected Healthcare/Public Health Indicators, 2015
  • Exhibit 3-6: United Kingdom, Selected Healthcare/Public Health Indicators, 2015
  • Exhibit 3-7: China, Selected Healthcare/Public Health Indicators, 2015
  • Exhibit 3-8: India, Selected Healthcare/Public Health Indicators, 2015
  • Exhibit 3-9: Japan, Selected Healthcare/Public Health Indicators, 2015

Note : Upon request (with paid report purchase), a selected set of procedure data can be provided in spreadsheet format (XLS or XLSX).

Back to Top